• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鲁-里格尔曼吸收法的应用。

Application of the Loo-Riegelman absorption method.

作者信息

Wagner J G

出版信息

J Pharmacokinet Biopharm. 1975 Feb;3(1):51-67. doi: 10.1007/BF01066595.

DOI:10.1007/BF01066595
PMID:1127578
Abstract

The Loo-Reigelman absorption method provides the correct A infinity/V1 value and the correct rate constant ka (if absorption is first order), whether metabolism occurs in compartment 1 only, compartment 2 only, or both compartments 1 and 2 of the two-compartment open models. In cases where there is metabolism in compartment 2, the disposition parameters estimated from intravenous data are only apparent and not the real values. The correct A infinity/V1 and ka values are obtained, however, only under conditions not hithertofore specified. Thes conditions are that there must be essentially no bias in the disposition parameters k12, k21 and kel, and in the C0 value estimated from the intravenous data, and that in the oral study a large number of interpolated plasma concentrations, as well as the observed plasma concentrations, must be used, especially for drugs with long half-lives. It is shown that application of the Guggenheim method to the initial At/V1, t values frequently provides a better method of estimating A infinity/V1 and ka than the classical method. If biased disposition parameters are used in application of the Loo-Reigelman method oral data, then essentially the correct ovalue of ka will be estimated, but the estimate of A infinity/V1 will be approximately equal to the true value of A infinity/V1 multiplied by the ratio of the biased C0 value (obtained in fitting the intravenous data) to the true C0 value of the intravenous data. The above indicates that intravenous data should be fitted by computer until there are no systematic deviations or trends and as small a sum of squared deviations as possible is obtainedmthe oral data should be fitted by spline or Akima methods, or similar procedures, to produce a function which passes through each observed plasma concentration and at the same time provides a large number of interpolated concentration data.

摘要

对于二室开放模型,无论代谢仅发生在第1室、仅发生在第2室,还是同时发生在第1室和第2室,Loo-Reigelman吸收法均可提供正确的A∞/V1值和正确的速率常数ka(如果吸收为一级过程)。在第2室存在代谢的情况下,根据静脉注射数据估算的处置参数只是表观值而非真实值。然而,只有在迄今未明确规定的条件下才能获得正确的A∞/V1和ka值。这些条件是,处置参数k12、k21和kel以及根据静脉注射数据估算的C0值必须基本无偏差,并且在口服研究中,必须使用大量内插血浆浓度以及实测血浆浓度,对于半衰期长的药物尤其如此。结果表明,将Guggenheim法应用于初始At/V1、t值时,与经典方法相比,通常能更好地估算A∞/V1和ka。如果在应用Loo-Reigelman法处理口服数据时使用了有偏差的处置参数,那么本质上可以估算出正确的ka值,但A∞/V1的估算值将约等于A∞/V1的真实值乘以有偏差的C0值(在拟合静脉注射数据时获得)与静脉注射数据的真实C0值之比。上述情况表明,静脉注射数据应由计算机进行拟合,直至不存在系统偏差或趋势,并获得尽可能小的偏差平方和;口服数据应采用样条法或Akima法或类似程序进行拟合,以生成一个通过每个实测血浆浓度且同时提供大量内插浓度数据的函数。

相似文献

1
Application of the Loo-Riegelman absorption method.鲁-里格尔曼吸收法的应用。
J Pharmacokinet Biopharm. 1975 Feb;3(1):51-67. doi: 10.1007/BF01066595.
2
Use of simultaneous computer fitting to estimate the apparent absorption rate constant.使用同步计算机拟合来估计表观吸收速率常数。
J Pharm Sci. 1986 May;75(5):452-5. doi: 10.1002/jps.2600750506.
3
Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.影响用于估算药物吸收速率的卢-里格尔曼方法误差的因素。关于实际采样方案的一些建议。
Arzneimittelforschung. 1983;33(5):757-60.
4
Estimation of absorption rate constant (ka) following oral administration by Wagner-Nelson, Loo-Riegelman, and statistical moments in the presence of a secondary peak.在存在二次峰的情况下,采用瓦格纳-尼尔森法、卢-里格尔曼法和统计矩法估算口服给药后的吸收速率常数(ka)。
Drug Metabol Drug Interact. 2004;20(1-2):85-100. doi: 10.1515/dmdi.2004.20.1-2.85.
5
Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.两室药代动力学模型中“翻转”现象的批判性分析
J Pharm Sci. 1976 Aug;65(8):1140-4. doi: 10.1002/jps.2600650804.
6
Evaluating drug absorption after oral administration. Some problems and some solutions.评估口服给药后的药物吸收。一些问题及一些解决方案。
Eur J Clin Pharmacol. 1984;26(2):255-9. doi: 10.1007/BF00630295.
7
A New Method for the Estimation of Absorption Rate Constant in Two-Compartment Model by Extravascular Administration.血管外给药估算双室模型吸收速度常数的新方法。
J Pharm Sci. 2020 May;109(5):1802-1810. doi: 10.1016/j.xphs.2020.01.025. Epub 2020 Feb 4.
8
A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data.一种在无静脉药代动力学数据情况下估算二室模型拟合药物吸收速率常数的新方法。
Front Pharmacol. 2023 May 4;14:1087913. doi: 10.3389/fphar.2023.1087913. eCollection 2023.
9
The area function method for assessing the drug absorption rate in linear systems with zero-order input.用于评估具有零阶输入的线性系统中药物吸收速率的面积函数法。
Pharm Res. 1989 Feb;6(2):133-9. doi: 10.1023/a:1015928509101.
10
Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation.仅来自口服数据或口服/静脉数据的药代动力学吸收图以及精确的鲁-里格尔曼方程。
J Pharm Sci. 1983 Jul;72(7):838-42. doi: 10.1002/jps.2600720738.

引用本文的文献

1
Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption.重新构建具有科学和监管意义的生物药剂学-药代动力学,以改善口服药物吸收。
Pharm Res. 2023 Sep;40(9):2167-2175. doi: 10.1007/s11095-023-03578-x. Epub 2023 Aug 3.
2
A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data.一种在无静脉药代动力学数据情况下估算二室模型拟合药物吸收速率常数的新方法。
Front Pharmacol. 2023 May 4;14:1087913. doi: 10.3389/fphar.2023.1087913. eCollection 2023.
3
In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.

本文引用的文献

1
Estimation of rate constants for absorption and elimination from blood concentration data.根据血药浓度数据估算吸收和消除速率常数。
J Pharm Sci. 1967 May;56(5):658-9. doi: 10.1002/jps.2600560531.
2
Use of computers in pharmacokinetics.计算机在药代动力学中的应用。
Clin Pharmacol Ther. 1967 Jan-Feb;8(1):201-18. doi: 10.1002/cpt196781part2201.
3
New method for calculating the intrinsic absorption rate of drugs.计算药物内在吸收速率的新方法。
注射用利培酮聚合物微球的体外-体内相关性
J Control Release. 2015 Nov 28;218:2-12. doi: 10.1016/j.jconrel.2015.09.051. Epub 2015 Sep 28.
4
Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.翻转药代动力学——实现处置的逆转:药物研发过程中的挑战与机遇
Ther Deliv. 2011 May;2(5):643-72. doi: 10.4155/tde.11.19.
5
Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.使用(SBE)7m-β-环糊精的氯丙嗪渗透泵片(OPT)的设计与评价
Pharm Res. 1999 Apr;16(4):549-54. doi: 10.1023/a:1018827214223.
6
Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.使用(SBE)7m-β-环糊精设计并评估用于泼尼松龙(一种难溶性药物)的渗透泵片(OPT)
Pharm Res. 1998 Oct;15(10):1562-8. doi: 10.1023/a:1011955117026.
7
Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption.用于体内药物吸收测定的Loo-Riegelman方法的数学基础及推广
J Pharmacokinet Biopharm. 1980 Feb;8(1):83-98. doi: 10.1007/BF01059450.
8
Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system.从共聚物给药系统中释放的纳曲酮控释的药代动力学定量分析。
J Pharmacokinet Biopharm. 1983 Aug;11(4):369-87. doi: 10.1007/BF01058956.
9
An area function method for estimating the apparent absorption rate constant.一种用于估计表观吸收速率常数的面积函数法。
Pharm Res. 1988 Jan;5(1):57-60. doi: 10.1023/a:1015819629884.
10
Do you need a pharmacokinetic model, and, if so, which one?你需要一个药代动力学模型吗?如果需要,是哪一种呢?
J Pharmacokinet Biopharm. 1975 Dec;3(6):457-78. doi: 10.1007/BF01059477.
J Pharm Sci. 1968 Jun;57(6):918-28. doi: 10.1002/jps.2600570602.
4
Pharmacokinetic profile of coumermycin A.香豆霉素A的药代动力学概况。
J Pharm Sci. 1970 Mar;59(3):309-13. doi: 10.1002/jps.2600590306.
5
Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression.基于样条法和秋间法的曲线拟合:插值误差的可能性及其抑制
Phys Med Biol. 1973 Jul;18(4):550-8. doi: 10.1088/0031-9155/18/4/306.
6
Pharmacokinetic analysis of blood level data interpreted by a two-compartment model.由二室模型解释的血药浓度数据的药代动力学分析。
Chem Pharm Bull (Tokyo). 1973 Jul;21(7):1458-69. doi: 10.1248/cpb.21.1458.
7
Kinetics of warfarin absorption in man.华法林在人体中的吸收动力学。
Clin Pharmacol Ther. 1973 Nov-Dec;14(6):955-61. doi: 10.1002/cpt1973146955.